Alzheimer’s disease is usually discussed in terms of plaques, tangles, and genetics. Dr. Stephen Cunnane has spent years studying another piece of the puzzle: what happens when the aging brain can no longer use glucose efficiently, and whether ketones can help fill that energy gap.
In this interview, Dr. Bret Scher and Dr. Cunnane discuss the metabolic side of cognitive decline, including insulin resistance, brain glucose metabolism, and why metabolic health may play an important role in both prevention and treatment.
generated summary
Why prevention is central
- Dementia, cognitive impairment, and Alzheimer's disease are increasingly prevalent and deeply feared because they can take away memory, thinking, independence, and the ability to relate to other people.
- Medical training gives far more attention to pharmacology than to metabolic health, lifestyle, and prevention, and the medical system makes prevention difficult to integrate into routine practice.
- Prevention is not miraculous, but hypertension, obesity, type 2 diabetes, cancer, and neurodegenerative disease can be pushed farther away by acting on modifiable risks earlier in life.
- Type 2 diabetes can be "cured" through prevention even after medications and insulin have begun.
Brain metabolism from infancy to aging
- The newborn brain is a "hybrid car": glucose and ketones are both normal fuels, ketones can supply about one-third of brain energy, and a healthy term infant's brain can consume about 75% of whole-body energy; premature or low-birthweight infants without adequate fat stores may therefore be vulnerable.
- Adult ketone therapy is connected to this normal infant physiology, while the modern pattern of rarely moving in and out of ketosis differs from the glucose-and-ketone cycling that would have been common across human life, and loss of that fuel switching is part of the dementia problem.
- Reduced brain glucose use in Alzheimer's disease has been known since early PET imaging, while George Cahill's 1967 fasting work established that ketones can become a major brain fuel during starvation. [1]
- The glucose problem begins before diagnosed Alzheimer's disease, including in genetic and sporadic forms and in otherwise healthy aging, so it cannot be explained only by neurons dying late in the disease.
The brain energy problem in Alzheimer's disease
- Aging together with carbohydrate-heavy diets, excess sugar, sedentary living, and insulin resistance can worsen low brain glucose use while suppressing endogenous ketone production, creating what amounts to chronic starvation of the brain.
- Plaques, tangles, amyloid, and tau are central to Alzheimer's neuropathology, but clearing plaque does not by itself restore the brain energy needed to learn, store information, and recover memories.
- Amyloid-directed drugs and metabolic approaches can be complementary; Alzheimer's disease is unlikely to be adequately addressed unless the brain energy deficit is addressed at the same time.
What the clinical trials show
- Trials of exogenous ketones, MCT, and ketogenic diets include unblinded and randomized studies, with some small successes and many neutral or negative outcomes; most have lasted only 8-12 weeks, while Alzheimer's changes slowly and long-term dietary adherence is difficult.
- Elizabeth Neal's ketogenic-diet randomized controlled trial in children with epilepsy demonstrates that such a diet trial can be done in neurology, although controlling diet in children is easier than maintaining a long ketogenic intervention in older adults. [2]
- Matthew Phillips's randomized crossover trial in Alzheimer's disease improved quality of life and daily function on a modified ketogenic diet, while specific memory and cognitive measures did not significantly improve. [3]
- Quality of life is often not measured, and attention, follow-up, group activity, and the sense that someone is caring for the participant can themselves produce a large placebo or control-group benefit.
- In two major multidomain prevention interventions in people at risk of Alzheimer's disease, the control-group effect was about three-quarters of the beneficial effect, consistent with exercise, cognitive training, social contact, and active care improving people's lives.
- Functional ability, communication with family and neighbors, and a better life matter more to patients than biomarker changes.
APOE4, disease stage, and heterogeneity
- One ketone-product study found cognitive benefit that was markedly weaker in APOE4 carriers, making genotype a plausible modifier of response.
- The roughly 40-versus-40, six-month MCT study in mild cognitive impairment found no APOE4 effect, but only about 10-12 APOE4 carriers were in each group, so the trial was not powered to settle that question. [4]
- APOE4 is currently more useful as a research tool than a clinical decision tool: noncarriers are not protected, homozygous carriers have higher risk, and testing can create misleading reassurance even though risk can still be mitigated.
- Prevention should start early because the same lifestyle risks also drive hypertension, obesity, cancer, and type 2 diabetes; severe type 2 diabetes is already occurring in teenagers, even to the point of kidney transplantation.
- Advanced Alzheimer's disease is not automatically beyond help: for most severely affected people the effort or cost may no longer be worthwhile, yet periods of lucidity and benefit are seen anecdotally, so there is no justified MMSE cutoff below which trying is automatically futile.
- Metabolic dysfunction is a contributing factor, not a guarantee that correcting metabolism will eliminate Alzheimer's disease; genetics, other diseases, infections, falls, head trauma, and concussion can all change the response.
- Beta-amyloid changes can be seen after concussion in university athletes in their twenties and can still leave a fingerprint decades later, illustrating how brain injuries and other exposures can accumulate alongside metabolic risk.
A multidomain lifestyle strategy
- Exercise, cognitive activity, sleep, stress, and metabolic health all matter, so multiple components are used because no single intervention has been shown to solve every case.
- A four-component intervention also hedges against imperfect adherence; insulin control is a major constraint, and overnight fasting, possibly around 16 hours, should allow endogenous ketone production to occur.
- Mild cognitive impairment changes slowly, so a statistically significant shift of one or two points on a memory test may not be clinically meaningful unless it changes daily life or quality of life.
Eric Sprott's funding and the new program
- Eric Sprott's donation creates the opportunity to combine research with public and clinician outreach; at age 81 he feels healthier on a mainly keto-carnivore diet, his partner has followed a ketogenic diet for more than 20 years, and the goal is for people and doctors to act on preventable risk.
- Useful action does not have to wait for another five years of research: refined carbohydrate can be reduced now, and exercise is important in part because it increases brain ketone uptake.
- Cutting carbohydrate intake by about 50% is already useful but may not raise ketones much, so MCT is added to increase ketone availability without demanding a strict ketogenic diet.
- A small retirement-home study showed that people in their eighties could sustain a reduced-carbohydrate diet while still receiving two smaller desserts a day by lowering the overall carbohydrate load, fruit juice, and soft drinks. [5]
- The main multidomain project combines reduced carbohydrate, MCT, exercise, and an omega-3 supplement, alongside knowledge mobilization through Keto Celebration and education designed to change health-professional practice.
Type 2 diabetes as an actionable Alzheimer's risk
- Prevention and slowing established disease are different goals, but type 2 diabetes is one of the top three or four modifiable risk factors for Alzheimer's disease and refined sugar intake is changeable.
- UK and North American type 2 diabetes programs, including Virta Health and David Unwin, can eliminate medications and insulin; the more precise terms are "remission" or "reversal," not "cure."
- Preventing or reversing type 2 diabetes does not guarantee prevention of Alzheimer's disease, but reducing a major risk factor should protect the heart, kidneys, and liver and is expected to delay memory problems: "forget Alzheimer's disease" and think below the neck.
- "Type 3 diabetes" draws attention to brain insulin resistance, but it may also steer attention toward diabetes drugs alone; reduced carbohydrate could potentially be combined with GLP-1, SGLT, or other appropriate drugs.
- Persistent medical resistance to reducing carbohydrate and sugar intake is the same century-long problem explored by Gary Taubes in Rethinking Diabetes. [6]
SPARCUS and the broader goal
- SPARCUS is the Sprott Prevent Alzheimer Research Collaboration at the University of Sherbrooke, built around research and getting the public to take prevention seriously.
- Clinician education can use CME, communities of practice, practitioner exchange, and the experience of patients who have succeeded with metabolic interventions.
- Metabolic health, mental health, and cognitive health are moving toward the same connected field, and philanthropy from people such as Eric Sprott and the Baszucki family can help change research priorities and medical practice.
References
- [07:18] Brain Metabolism during Fasting — https://doi.org/10.1172/JCI105650
- [12:27] The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial — https://doi.org/10.1016/S1474-4422(08)70092-9
- [13:18] Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease — https://doi.org/10.1186/s13195-021-00783-x
- [16:20] A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT — https://doi.org/10.1002/alz.12206
- [27:55] A reduced carbohydrate diet improves glycemic regulation in hyperglycemic older people in a retirement home: the SAGE study — https://doi.org/10.1139/apnm-2024-0277
- [34:52] Rethinking Diabetes — https://www.penguinrandomhouse.com/books/561552/rethinking-diabetes-by-gary-taubes/



Do you have crypto donation options? I checked all the posted payment providers above and didn't see any
there is a post from 3 years ago with crypto donation addresses, are they still valid? https://lemmy.world/post/12531572